TENOFOVIR DISOPROXIL FUMARATE

CHEBI:CHEBI_747789

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20241231
route
ORAL
marketing_start_date
20011001
spl_id
16be9dc8-26f8-4ee6-b6fc-5972cdcc0ad4
package_ndc
65015-667-61
labeler_name
Cipla USA Inc.
package_description
100 kg in 1 DRUM (65015-667-61)
rxcui
1243346
active_ingredient_strength
15 kg/15kg
manufacturer_name
REMEDYREPACK INC.
package_marketing_start_date
07-MAR-12
active_ingredient_name
TENOFOVIR DISOPROXIL FUMARATE
unii
OTT9J7900I
pharm_class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
spl_set_id
7f0bc342-0a0a-1d28-e053-2991aa0a28b9
upc
0342291800304
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
dosage_form
TABLET, COATED
generic_name
Tenofovir disoproxil fumarate
brand_name
Tenofovir disoproxil fumarate
brand_name_base
Tenofovir disoproxil fumarate
product_ndc
65015-667
application_number
ANDA078800